highly significantp < 0.001
Comparing survival in patients with localized disease at diagnosis to survival in patients with the metastatic disease showed a highly significant difference, p < 0.001 ( Supplemental Figure S1b ). 3.3.
Comparing survival in patients with localized disease at diagnosis to survival in patients with the metastatic disease showed a highly significant difference, p < 0.001 ( Supplemental Figure S1b ). 3.3.
The pattern was the same for patients with localized disease at diagnosis, with the highest scores in HS-mGPS, ACBS, and ACBSm being significant predictors of OS, while the Choi model did not reach statistical significance.